Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
HistoSonics Completes Enrollment in #HOPE4KIDNEY Trial Evaluating Non-Invasive Histotripsy to Treat Kidney Tumors
-
Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Annual Congress
-
KB Home Announces the Grand Opening of Its Newest Community in a Prime Meridian, Idaho Location
-
SABINE ROYALTY TRUST ANNOUNCES MONTHLY CASH DISTRIBUTION FOR JUNE 2025
-
Franklin Templeton Announces Distribution Rates for Putnam Closed-End Funds
-
Franklin Templeton Announces 19(a) Notices for Closed-End Municipal Funds
-
SimSpace Appoints Industry Veteran Peter Lee as Chief Executive Officer
-
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Thousands of Convergint Colleagues Revitalize Hundreds of Communities and Increase School Safety Globally for Annual Day of Service
-
RLJ Lodging Trust Announces Second Quarter 2025 Earnings Release and Conference Call Dates
-
Bone Biologics Announces 1-for-6 Reverse Stock Split
-
American Rebel CEO to Perform at Bristol Dragway and American Rebel Light Beer to be Featured at Trackside Bar and Beer Garden
-
PetVivo and Commonwealth Partner to Advance Equine Wellness Across Thoroughbred Racing
-
Melcor Developments Ltd. Announces Normal Course Issuer Bid
-
DeFi Dev Corp. Partners with Drift Protocol to List dfdvSOL Liquid Staking Token
-
Arcutis to Present New Long-Term Results of ZORYVE® (roflumilast) Cream at the 2025 Revolutionizing Atopic Dermatitis Conference
-
Spur Therapeutics Presents Positive New Preclinical Data on Its Gene Therapy Candidate for GBA1 Parkinson’s Disease at 2025 GBA1 Meeting
-
Aytu BioPharma Announces Exclusive Agreement with Fabre-Kramer Pharmaceuticals to Commercialize First-in-Class Antidepressant EXXUA(TM) (gepirone) Extended-Release Tablets in the United States
-
Composition of Hiab’s Shareholders’ Nomination Board
-
Preventing “Ozempic Face”: How the Naderi Center Combines Aesthetics and Weight Loss for Total Facial Rejuvenation
-
Divorced and Facing IRS Collection? Clear Start Tax Outlines How Innocent Spouse Relief Could Save You Thousands
-
‘The Future’ Arrives: Luna Atoms’ Debut Visual Album Out Now!
-
Talkspace to Participate in Upcoming Investor Conferences
-
Time is Running Out to Preserve Princess Diana's Legacy
-
How AirCarbon Is Turning Greenhouse Gases Into Ocean-Friendly Plastic Alternatives
-
Dimensional Fund Advisors Ltd. : Form 8.3 - UNITE GROUP PLC/THE - Ordinary Shares
-
Pocket-Sized Gold Mine: Bitcoin Solaris Nova App Lets Anyone Build Crypto Wealth From Their Phone
-
Dimensional Fund Advisors Ltd. : Form 8.3 - PRIMARY HEALTH PROPERTIES - Ordinary Shares
-
Bipartisan SEPSIS Act Reintroduced in U.S. Senate With Broad Support
-
Uxin to Report First Quarter 2025 Financial Results on June 12, 2025
-
Dimensional Fund Advisors Ltd. : Form 8.3 - GREENCORE GROUP PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - EMPIRIC STUDENT PROPERTY PLC - Ordinary Shares
-
Pizza Nova raises $231,045 for Variety – the Children’s Charity of Ontario with 2025 That’s Amore Pizza for Kids fundraiser
-
Phio Pharmaceuticals Announces Strategic Initiative to Create Awareness of the Comprehensive INTASYL siRNA Portfolio
-
CAE announces renewal of normal course issuer bid
-
Norwegian Tech Firm Builds Military Command Center in 24 Hours
-
Issue of Equity
-
Haier's Strategic Partnership with Roland-Garros Enters Third Year, Driving Shared Values of Excellence
-
Akto Launches Industry's First MCP Security Platform
-
Neural's Partner CWE to Open Store No. 16 in the City of Bonn and Invitation to Meet Hanf.com at Mary Jane Berlin 2025
-
AYR Provides Update on Anticipated Cease Trade Order
-
BE Resources Announces Closing of Debt Settlement
-
Matador Technologies Inc. Announces Closing of Final Tranche of Non-Brokered Private Placement to Support Bitcoin Acquisition
-
Sun Belt State Transportation Agency to Deploy 150 Rekor Discover® Systems Under Rekor's Data-as-a-Service Model
-
TG Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
-
Accuray Announces Convertible Notes Exchange and Refinancing of Existing Credit Facilities
-
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
OS Therapies Submits Request for Regenerative Medicine Advanced Therapy (RMAT) Designation to U.S. FDA for OST-HER2 in the Prevention of Metastases in Recurrent, Fully-Resected, Lung Metastatic Pediat
-
Bowman Announces Authorization of New $25 Million Share Repurchase Program
-
The Change Company Secures $94 Million Judgement
